|
|
ACADIA Pharmaceuticals (ACAD) |
StreetInsider.com
May 15
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Acadia+Pharmaceuticals%2C+%28ACAD%29+Prices+8M+Share+Offering+at+%2412.50Sh/8339618.html for the full story.
Benzinga
May 14
Comment
ACADIA Pharmaceuticals (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance as to whether or when the...
StreetInsider.com
May 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Acadia+Pharmaceuticals%2C+Inc.+%28ACAD%29+Reports+In-Line+Q1+Loss/8313420.html for the full story.
Forbes
May 6
Comment
ACADIA Pharmaceuticals Inc. (ACAD) is expected to book a narrower loss than a year ago when it reports first quarter earnings on Tuesday, May 7, 2013 with analysts expecting a loss of 8 cents per share, up from a loss of 12 cents per share a year...
Red Orbit
Apr 23
Comment
Lee Rannals for redOrbit.com – Your Universe Online
Researchers wrote in the journal Nature Communications they have reconstructed the genetic history of modern Europe.
The team was composed of scientists from the University of Adelaide's...
Benzinga
Apr 12
Comment
In a report published Friday, Jefferies analyst Thomas Wei reiterated a Buy rating on ACADIA Pharmaceuticals (NASDAQ: ACAD), and raised the price target from $13.00 to $18.00.
In the report, Wei noted, “Following discussions with the FDA,...
StreetInsider.com
Apr 11
Comment
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.
52-Week High:
Rite Aid Corp. (NYSE: RAD) $2.15. Rite Aid blasting over 20 percent to a new annual high today after issuing...
StreetInsider.com
Apr 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Piper+Jaffray+Upgrades+Acadia+Pharmaceuticals+%28ACAD%29+to+Overweight/8247874.html for the full story.
Benzinga
Apr 11
Comment
ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) shares moved up 46.93% to $11.71 at 10:54 am. The volume of ACADIA Pharmaceuticals shares traded was 1410% % higher than normal. ACADIA Pharmaceuticals announced following its FDA meeting, it no longer...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
